News centre | United Kingdom

Jun 03, 2020

NHS Ayrshire & Arran Selects Philips Digital Pathology Solution
to Completely Transform the University Hospital Crosshouse’s Approach to Diagnostics and Care  


  • Introducing remote diagnostic capabilities will bring improvements in safety, quality and efficiency including the real-time review of cases


  • Digital pathology capabilities will become part of the hospital’s post-COVID-19 care environment, enabling pathologists to socially distance when needed and also introduce more flexible ways of working

Guildford, United Kingdom – Royal Philips (NYSE: PHG, AEX: PHIA), is enabling the University Hospital Crosshouse, Kilmarnock, part of NHS Ayrshire & Arran, to introduce remote digital pathology capabilities that will help the hospital best serve residents of Ayrshire & Arran.  It may also help set a new standard of diagnostic services and care for communities located outside of main city centres.


To enable this, Philips is providing the University Hospital Crosshouse with the Philips IntelliSite Pathology Solution, comprising of an Ultra Fast Scanner and Image Management System. This product will help reduce pressure on the University Hospital Crosshouse’s pathology service by streamlining the workflow and extending collaboration with the object of increasing diagnostic confidence. In doing so, the University Hospital Crosshouse also opens the future possibility of introducing computational pathology, which would further enhance diagnostic decision-making, improve efficiency and support the University Hospital Crosshouse in gaining new insights.   

Dr Lorna Cottrell, Consultant Pathologist commented, “We strongly believe that digital pathology offers the potential to dramatically change the way we will be able to deliver our pathology service, that will bring improvements in safety, quality and efficiency. Creating new working patterns will help address many of the challenges facing everyone in pathology over the next few years – even more so in the way we are adapting to a new way of working today due to the COVID-19 pandemic. Home reporting has the potential to be one of the biggest advantages to the way our team works. I am not able to access fibre broadband where I live so initially I thought the speed of image transfer might be too slow, I have noticed very little difference between looking at slides at work and at home.”


The Philips solution will allow remote access facilities, enabling flexible options for working at home. At a time where the NHS will now be working in the shadow of coronavirus, digital pathology will enhance the ‘new normal’, supporting implementation of social distancing to protect the University Hospital Crosshouse’s pathologists and provide resilience to the department.


It also offers pathologists more flexible options for working, such as working from home for specified number of days per week, eliminating the need to face a difficult commute five days a week, or spending a proportion of the day working from home, which means travelling at the busiest times of day could be avoided.  The necessity of spending hours at the microscope can also be reduced, making the working environment more comfortable for pathologists, who can be prone to suffering from back and neck problems when spending a significant amount of time hunched over a microscope.


Furthermore, introducing a digital pathology solution brings the ability to send digital cases for remote review by experts with the expectation to have high quality and faster diagnoses for the hospital’s patients. Digital slides can also be used at multi-disciplinary meetings as an educational to review in real time to answer questions and facilitate clinical discussion immediately, enhancing the delivery of timely and quality patient care.


“We are energised by the many possibilities that introducing digital pathology into the hospital might unlock,” continued Cottrell.  “If our learnings inspire other hospitals and trusts in other coastal or rural communities to do the same, it would be exciting to demonstrate that digital pathology solutions have a role to play in many different sized communities – not just hospitals in urban or city centres.”



The University Hospital Crosshouse Kilmarnock offers services to a population of around 400,000 people. Over the years, it has invested significantly in modern community and hospital facilities, and the also in the training of its highly qualified teams in providing care to the members of its community.


For more information on the Philips IntelliSite Pathology Solution, please visit:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company, focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnosis imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.    Philips’ health technology portfolio generated in 2016 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News from Philips is located at

Click here to read moreClick here to read less



Media assets

Share on social media

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.